|
Originally published In Press as doi:10.1194/jlr.D200027-JLR200 on September 16, 2002
Journal of Lipid Research, Vol. 43, 2196-2204, December 2002
Copyright © 2002 by Lipid Research, Inc.
Novel d- -tocopherol derivative as a prodrug for d- -tocopherol and a two-step prodrug for S- -CEHC
Jiro Takata1,*,
Ryoji Hidaka*,
Akihiko Yamasaki*,
Akihiro Hattori ,
Takeshi Fukushima ,
Maiko Tanabe ,
Kazuhisa Matsunaga*,
Yoshiharu Karube* and
Kazuhiro Imai
* Faculty of Pharmaceutical Sciences, Fukuoka University, Nanakuma, Johnan-ku, Fukuoka 814-0180, Japan
Laboratory of Bio-Analytical Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
1 To whom correspondence should be addressed. e-mail: jtakata{at}fukuoka-u.ac.jp
d- -Tocopherol ( -Toc) and its major metabolite, 2, 7, 8-trimethyl-2S-(ß-carboxyethyl)-6-hydroxychroman (S- -CEHC), are currently receiving attention concerning their unique pharmacological activities. In order to achieve the efficient delivery of -Toc and S- -CEHC in vivo, we synthesized d- -tocopheryl N,N-dimethylglycinate hydrochloride ( -TDMG) as a water-soluble prodrug of -Toc and a two-step prodrug of S- -CEHC. -TDMG is a solid (mp 161163°C) and is quite soluble in water over 50 mM. The hydrolysis of -TDMG was effectively catalyzed by esterases in rat and human liver microsomes. The disposition of -TDMG after iv administration in rats was compared with that of -Toc solubilized with the surfactant, polyoxyethylene hydrogenated castor oil. The plasma and liver levels of -Toc rapidly increased after the iv administration of the -TDMG. The liver availability of -Toc after the administration of -TDMG was two times higher than that of the -Toc administration. The relative systemic availability of S- -CEHC after the -TDMG administration was an equivalent value (102%), and the mean residence time of S- -CEHC was eight times longer than the racemic -CEHC administration.
Based on these results, -TDMG was identified as the most promising water-soluble prodrug of -Toc and the two-step prodrug of S- -CEHC.
Abbreviations: AUC, area under the concentration-time curve; DBD-PZ, 4-N,N-dimethylaminosulfonyl-7-piperazino-2,1,3-benzoxadiazole; FD-MS, field desorption mass spectrometry; HCO-60, polyoxyethylene hydrogenated castor oil; 1H-NMR, proton nuclear magnetic resonance spectrometry; -Toc, d- -tocopherol; -TDMG, d- -tocopheryl N,N-dimethylglycinate hydrochloride; MRT, mean residence time; R- -CEHC, 2,7,8-trimethyl-2R-(ß-carboxyethyl)-6-hydroxychroman; S- -CEHC, 2,7,8-trimethyl-2S-(ß-carboxyethyl)-6-hydroxychroman; TFA, trifluoroacetic acid Supplementary key words water-soluble prodrug drug delivery d- -tocopherol two-step prodrug

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Akaho, J. Takata, T. Fukushima, K. Matsunaga, A. Hattori, R. Hidaka, K. Fukui, M. Yoshida, T. Fujioka, Y. Karube, et al.
Preparation and In Vivo Evaluation of a Water-Soluble Prodrug for 2R-{gamma}-Tocotrienol and as a Two-Step Prodrug for 2,7,8-Trimethyl-2S-({beta}-carboxyethyl)-6-hydroxychroman (S-{gamma}-CEHC) in Rat
Drug Metab. Dispos.,
September 1, 2007;
35(9):
1502 - 1510.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|